Bristol-Myers Squibb (BMY) Announces Presentation of Significant Opdivo Phase 3 Data in SCCHN
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) announced the first presentation of data from CheckMate -141, a Phase 3 open-label, randomized trial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
